Browsing by Author Field, Kathryn

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2015Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumabGebski, Val; Price, Timothy; Sjoquist, Katrin; et al, Various; Field, Kathryn; Gibbs, Peter; McKendrick, J; Nott, Louise M; Roohullah, Aflah; Shapiro, Jeremy; Tran, Ben; Wong, Hui-Li; Yip, Desmond; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreGastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab, World Journal of Gastroenterology, vol.21, 17, 2015,pp 5352-5358
2017Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastomaBarnes, Elizabeth; Espinoza, David; King, Madeleine; Sawkins, Kate; Simes, Robert John; Cher, L; Field, Kathryn; Hovey, Elizabeth; Nowak, Anna K.; Rosenthal, Mark; Wheeler, Helen; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Psychology; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreHealth-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma, Journal of Neuro-Oncology, vol.133, N/A, 2017,pp 623-631
2009Predictors of the use of Complementary and Alternative Medicine (CAM) by women at high risk for breast cancerButow, Phyllis; Price, Melanie; Field, Kathryn; Friedlander, Michael; Hopper, John L.; Jenkins, M. A.; Keogh, Louise; Lindeman, G J; McKinley, Joanne M; McLachlan, Sue Anne; Phillips, Kelly-Anne; Weideman, Prue C; Psychology; PsychologyPredictors of the use of Complementary and Alternative Medicine (CAM) by women at high risk for breast cancer, European Journal of Cancer, vol.45, 4, 2009,pp 551-560
2012Preliminary analysis of the cost-effectiveness of the National Bowel Cancer Screening Program: demonstrating the potential value of comprehensive real world dataField, Kathryn; Ananda, Sumitra; Carter, Rob; Croxford, Matthew; Gibbs, Peter; Jones, Ian T.; Keating, Catherine; Kosmider, Suzanne; Tran, Ben; School of Public Health: NH&MRC Clinical Trials CentrePreliminary analysis of the cost-effectiveness of the National Bowel Cancer Screening Program: demonstrating the potential value of comprehensive real world data, Internal Medicine Journal, vol.42, 7, 2012,pp 794-800
2015Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastomaBarnes, Elizabeth; Brown, Christopher; Livingstone (nee Ratcliffe), Ann; Sawkins, Kate; Simes, Robert John; Cher, Lawrence; Field, Kathryn; Fitt, Greg; Freilich, Ron; Hovey, Elizabeth; Nowak, Anna; Phal, Pramit M; Rosenthal, M.A.; Wheeler, Helen; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreRandomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma, Neuro-Oncology, vol.17, 11, 2015,pp 1504-1513
2017The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET)Barnes, Elizabeth; Sawkins, Kate; Simes, Robert John; Cher, Lawrence; Field, Kathryn; Fitt, G; Goh, Christine; Hovey, Elizabeth; Nowak, Anna K.; Phal, Pramit M.; Rosenthal, Mark; Wheeler, Helen; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreThe role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET), Cancer, vol.123, 18, 2017,pp 3576-3582